Published within
|«
«
|
1
|
2
|
3
|
4
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
This report analyzes the vaccine market in India, and provides recommendations for both local manufacturers operating in the space and Western players looking to enter into this lucrative market.
Published By Datamonitor
|
18 Apr 2012 |
$5700
|
Report
|
An overview of partnering trends in developed and emerging pharmaceutical markets in the Asia Pacific region from Q3 2010 to Q2 2011, with discussion of the drivers of recent deals and analysis of key deals and agreements in individual countries.
Published By Datamonitor
|
21 Dec 2011 |
$7600
|
Report
|
Datamonitor’s report Biosimilars: Regulatory Update provides analysis on key developments in biosimilar regulations globally. It includes an overview of the background behind these events and popular strategic responses.
Published By Datamonitor
|
08 Dec 2011 |
$1900
|
Report
|
Datamonitor’s report Orphan Drug Trends provides an overview of orphan drug regulations in the major pharmaceutical markets, including pricing and reimbursement issues and an analysis of Big Pharma’s growing interest in orphan drugs.
Published By Datamonitor
|
25 Nov 2011 |
$5700
|
Report
|
An overview of merger and acquisition (M&A) trends in developed and emerging pharmaceutical markets in the Asia Pacific region from Q1 2007 to Q2 2011, with discussion of the drivers of recent deals and analysis of key M&As in individual countries.
Published By Datamonitor
|
24 Nov 2011 |
$7600
|
Report
|
Review of the Indian oncology market including a market overview, discussion of key companies, evaluation of strengths, weaknesses, opportunities and threats, and discussion of market penetration strategies.
Published By Datamonitor
|
27 Oct 2011 |
$5700
|
Report
|
Biosimilars: India Update provides analysis on the Indian copy biologics market. It includes an overview of drivers and resistors to biologic uptake, market access strategies, key domestic biologic players and future development trends.
Published By Datamonitor
|
14 Oct 2011 |
$1900
|
Report
|
Datamonitor’s report BRIC: Pricing, Reimbursement, and Regulatory Update provides an update of changes to pricing, reimbursement and regulation in Brazil, Russia, India and China during the first half of 2011.
Published By Datamonitor
|
08 Sep 2011 |
$1900
|
Report
|
Datamonitor’s report Generics: Regulatory Update provides an update of changes to generic regulations that occurred in the first half of 2011.
Published By Datamonitor
|
30 Aug 2011 |
$1900
|
Report
|
The launch and uptake of biologics has grown across India – primarily in urban areas – but affordability is a major limiting factor, thereby providing an opportunity for the pharmaceutical companies manufacturing cost-effective biosimilars.
Published By Datamonitor
|
25 Aug 2011 |
$5700
|
|«
«
|
1
|
2
|
3
|
4
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.